These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 29625940

  • 1. Incidence of drug interactions in intensive care units in tertiary care settings: Classification, facts and measures.
    Hasnain H, Ali H, Zafar F, Sial AA, Alam S, Beg AE, Bushra R, Rizvi M, Khan MA, Shareef H, Naqvi GR, Tariq A.
    Pak J Pharm Sci; 2018 Mar; 31(2(Suppl.)):669-675. PubMed ID: 29625940
    [Abstract] [Full Text] [Related]

  • 2. Potential drug-drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study.
    Moura C, Prado N, Acurcio F.
    Clin Drug Investig; 2011 Mar; 31(5):309-16. PubMed ID: 21344954
    [Abstract] [Full Text] [Related]

  • 3. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
    Ramos GV, Guaraldo L, Japiassú AM, Bozza FA.
    J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for potential drug-drug interactions in intensive care unit patients.
    Janković SM, Pejčić AV, Milosavljević MN, Opančina VD, Pešić NV, Nedeljković TT, Babić GM.
    J Crit Care; 2018 Feb; 43():1-6. PubMed ID: 28822348
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of potential drug - drug interactions in the cardiothoracic intensive care unit patients in a Chinese tertiary care teaching hospital.
    Wang H, Shi H, Wang N, Wang Y, Zhang L, Zhao Y, Xie J.
    BMC Pharmacol Toxicol; 2022 Jun 14; 23(1):39. PubMed ID: 35701808
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study.
    Khan Q, Ismail M, Haider I, Khan F.
    Int J Clin Pharm; 2017 Dec 14; 39(6):1256-1264. PubMed ID: 28895028
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria.
    Olumuyiwa JF, Akinwumi AA, Ademola OA, Oluwole BA, Ibiene EO.
    Niger Postgrad Med J; 2017 Dec 14; 24(2):88-92. PubMed ID: 28762362
    [Abstract] [Full Text] [Related]

  • 12. The prevalence of potentially beneficial and harmful drug-drug interactions in intensive care units.
    Mehralian HA, Moghaddasi J, Rafiei H.
    Drug Metab Pers Ther; 2019 Mar 19; 34(1):. PubMed ID: 30903758
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Potential drug-drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan.
    Ismail M, Khan F, Noor S, Haider I, Haq IU, Ali Z, Shah Z, Hassam M.
    Int J Clin Pharm; 2016 Oct 19; 38(5):1052-6. PubMed ID: 27365090
    [Abstract] [Full Text] [Related]

  • 17. Potential drug-drug interactions in cardiothoracic intensive care unit of a pulmonary teaching hospital.
    Farzanegan B, Alehashem M, Bastani M, Baniasadi S.
    J Clin Pharmacol; 2015 Feb 19; 55(2):132-6. PubMed ID: 25369984
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Improving medication safety in the Intensive Care by identifying relevant drug-drug interactions - Results of a multicenter Delphi study.
    Bakker T, Klopotowska JE, de Keizer NF, van Marum R, van der Sijs H, de Lange DW, de Jonge E, Abu-Hanna A, Dongelmans DA, SIMPLIFY Study Group.
    J Crit Care; 2020 Jun 19; 57():134-140. PubMed ID: 32145656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.